Correspondence 0001493152-24-021308 from Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals, Inc.
Date: May 24, 2024 · CIK: 0001533743 · Accession: 0001493152-24-021308

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-279588

Date

May 24, 2024

Author

Chief

Form

CORRESP

Company

Processa Pharmaceuticals, Inc.

Letter

Processa Pharmaceuticals, Inc.

Coca Cola Drive, Suite 106

Hanover, Maryland 21076

May 24, 2024

VIA EDGAR Correspondence

United States Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, D.C. 20549

Attn: Ms. Jessica Dickerson

Re: Acceleration of Effective Date

Processa Pharmaceuticals, Inc.

Registration Statement on Form S-3 (File No. 333-279588)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Processa Pharmaceuticals, Inc. (the “Registrant”), hereby requests that the effective date of the above-referenced Registration Statement (the “Registration Statement”), be accelerated so that the Registration Statement becomes effective under the Securities Act by 4:30 p.m., Eastern Time, on May 28, 2024, or as soon thereafter as practicable.

The Registrant respectfully requests that you notify Mr. Michael Kirwan of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 633-8913.

Very
truly yours,
Processa
Pharmaceuticals, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Processa
Pharmaceuticals, Inc.

7380
Coca Cola Drive, Suite 106

Hanover,
Maryland 21076

May
24, 2024

VIA
EDGAR Correspondence

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
D.C. 20549

Attn:
Ms. Jessica Dickerson

    Re:
    Acceleration
    of Effective Date

    Processa
    Pharmaceuticals, Inc.

    Registration
    Statement on Form S-3 (File No. 333-279588)

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Processa Pharmaceuticals, Inc. (the “Registrant”),
hereby requests that the effective date of the above-referenced Registration Statement (the “Registration Statement”), be
accelerated so that the Registration Statement becomes effective under the Securities Act by 4:30 p.m., Eastern Time, on May 28, 2024,
or as soon thereafter as practicable.

The
Registrant respectfully requests that you notify Mr. Michael Kirwan of Foley & Lardner LLP of such effectiveness by a telephone call
to (904) 633-8913.

    Very
    truly yours,

    Processa
    Pharmaceuticals, Inc.

    By:
    /s/
    George Ng

    George
    Ng

    Chief
    Executive Officer

SecProbe.io